DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Mar 31, 2017 · 9y ago · Accession 0001628280-17-003206
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Mar 31, 2017
- Report date
- May 12, 2017
- Document
- def14aproxystatement.htm
- Size
- 802 KB